Use of glatiramer acetate between 2010 –2015: effectiveness, safety and reasons to start GA as first or second line treatment in Swiss multiple sclerosis patients

Glatiramer acetate (GA) is one of the first therapies approved for multiple sclerosis (MS). We prospectively included and monitored drug-na ïve and pre-treated MS patients who had been prescribed GA for 1 year,...

Source: BMC Neurology - July 12, 2019 Category: Neurology Authors: Chiara Zecca, Giulio Disanto, Rosaria Sacco, Gianna C. Riccitelli and Claudio Gobbi Tags: Research article Source Type: research